[1]
|
Rajeev, G. and Ravinder, S. (2017) Rao Recent Trends in Epidemiology of Dyslipidemias in India. Indian Heart Journal, 63, 382-392. https://doi.org/10.1016/j.ihj.2017.02.020
|
[2]
|
Ryoo, J.H. (2011) Apo B Is Highly Associated with the Risk of Coronary Heart Disease as Estimated by the Farmingham Risk Score in Healthy Korean Men. The Korean Academy of Medical Sciences, 26, 631-636.
https://doi.org/10.3346/jkms.2011.26.5.631
|
[3]
|
National Cholesterol Education Program (NCEP) Expert Panel On detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Re-port of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation, 106, 3143-3421. https://doi.org/10.1161/circ.106.25.3143
|
[4]
|
Anderson, K.M., Wilson, P.W., Odell, P.M. and Kannel, W.B. (1991) An Updated Coronary Risk Profile. A Statement for Health Professionals. Circulation, 83, 356-362. https://doi.org/10.1161/01.CIR.83.1.356
|
[5]
|
Walldius, G. (2006) The Apo B/Apo AI Ratio: A Strong, New Risk Factor for CVD and Target for Lipid Lowering Therapy. A Review of Evidence. Journal of Internal Medicine, 259, 493-519.
https://doi.org/10.1111/j.1365-2796.2006.01643.x
|
[6]
|
Shai, I., Rimm, E.B. and Hankinson, S.E. (2004) Multivar-iate Assessment of Lipid Parameters as Predictors of CHD among Post Menopausal Women. Circulation, 110, 2824-2830. https://doi.org/10.1161/01.CIR.0000146339.57154.9B
|
[7]
|
Sniderman, A.D. and Williams, K. (2011) A Meta-Analysis of Low Density Lipoprotein Cholesterol, Non-High Density Lipoprotein Cholesterol and Apolipopro-tein B as Markers of Cardiovascular Risk. Circulation: Cardiovascular Quality and Outcomes, 4, 337-345. https://doi.org/10.1161/CIRCOUTCOMES.110.959247
|
[8]
|
Sabino, A.P. and De Oliveria Sousa, M. (2008) Apo B/Apo A-I Ratio in Young Patients with Ischemic Cerebral Stroke or Peripheral Arterial Disease. Translational Research, 152, 113-118. https://doi.org/10.1016/j.trsl.2008.06.005
|
[9]
|
Mashayekhi, N.R. (2014) The Correlation between Serum Apo A1 and B and Coronary Artery Disease as Well as Its Severity. International Cardiovascular Research Journal, 8, 1-5.
|
[10]
|
Sattar, N., Williams, K., Sniderman, A.D., et al. (2004) Comparison of the Associations of Apolipoprotein B and Non-High Density Lipoprotein Cholesterol with Other Cardiovascular Risk Factors in Patients with Metabolic Syndrome in the Insulin Resistance Atherosclerosis Study. Circulation, 110, 2687-2693.
https://doi.org/10.1161/01.CIR.0000145660.60487.94
|
[11]
|
Walldius, G., Jungner, I., Holme, I., Aastveit, A.H., Kolar, W. and Steiner, E. (2001) High Apolipoprotein B, Low Apolipoprotein A-I, and Improvement in the Prediction of Fatal Myocardial Infarction (AMORIS Study): A Prospective Study. Lancet, 358, 2026-2033. https://doi.org/10.1016/S0140-6736(01)07098-2
|
[12]
|
Yusuf, S., Hawken, S., Ounpuu, S., et al. (2004) Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (The INTERHEART Study): Case-Control Study. Lancet, 364, 937-952.
https://doi.org/10.1016/S0140-6736(04)17018-9
|
[13]
|
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Pro-gram (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treat-ment Panel III). JAMA, 285, 2486-2497.
https://doi.org/10.1001/jama.285.19.2486
|
[14]
|
Cui, Y., Blumenthal, R.S., Flaws, J.A., et al. (2001) Non-High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality. Archives of Internal Medicine, 161, 1413-1419.
https://doi.org/10.1001/archinte.161.11.1413
|
[15]
|
Pischon, T., Girman, C.J. and Sacks, F.M. (2005) Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men. Circulation, 112, 3375-3383.
https://doi.org/10.1161/CIRCULATIONAHA.104.532499
|
[16]
|
Levinson, S.S. (2002) High Density and Be-ta-Lipoprotein Screening for Risk of Coronary Artery Disease in the Context of New Findings Associated with Reverse Cholesterol Transport. Annals of Clinical & Laboratory Science, 32, 123-136.
|
[17]
|
Bittner, V., Hardison, R. and Kelsey, S.F. (2002) Non-High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation, 106, 2537-2542.
https://doi.org/10.1161/01.CIR.0000038496.57570.06
|
[18]
|
Kathariya, G. and Aggarwal, J. (2020) Is Evaluation of Non-HDL-C Better than Calculated LDL-C in CAD Patients? MMIMSR Experiences. Indian Heart Journal, 72, 189-191. https://doi.org/10.1016/j.ihj.2020.05.008
|
[19]
|
Ridker, P.M., Rifai, N., Cook, N.R., et al. (2005) Non- HDL Cholesterol, Apolipoproteins A-I and B100, Standard Lipid Measures, Lipid Ratios and CRP as Risk Factors for Cardiovascular Disease in Women. JAMA, 294, 326-333.
https://doi.org/10.1001/jama.294.3.326
|
[20]
|
Grundy, S.M. (2002) Low Density Lipoprotein, Non-High Density Lipoprotein and Apolipoprotein B as Targets of Lipid Lowering Therapy. Circulation, 106, 2526-2529. https://doi.org/10.1161/01.CIR.0000038419.53000.D6
|
[21]
|
Emerging Risk Factors Collaboration (2012) Li-pid-Related Markers and Cardiovascular Disease Prediction. JAMA, 307, 2499-2506. https://doi.org/10.1001/jama.2012.6571
|
[22]
|
You, J.Y., Zhen, H., Lu, G.P. and Chen, Z.Y. (2020) Association between the Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprote in Cholesterol Ratio and the Risk of Coronary Artery Disease. BioMed Research International, 2020, Article ID: 7146028. https://doi.org/10.1155/2020/7146028
|
[23]
|
Valmore, B., Torres, W., Salazar, J., et al. (2018) Non-HDL Cholester-ol Is Better than LDL-C at Predicting Atherosclerotic Cardiovascular Disease Risk Factors Clustering, Even in Subjects with Near-to-Normal Triglycerides: A Report from a Venezuelan Population. F1000Research, 7, 504. https://doi.org/10.12688/f1000research.13005.1
|
[24]
|
Wongcharoen, W., Sutthiwutthichai, S., Gunaparn, S., et al. (2017) Wongcharoen Is Non-HDL-Cholesterol a Better Predictor of Long Term Outcome in Patients after Acute Myo-cardial Infarction Compared to LDL-Cholesterol. BMC Cardiovascular Disorders, 17, Article No. 10. https://doi.org/10.1186/s12872-016-0450-9
|
[25]
|
Liu, J., Sempos, C., Donahue, R.P., et al. (2005) Joint Distribu-tion of Non-HDL and LDL Cholesterol and Coronary Heart Disease Risk Prediction among Individuals with and without Diabetes. Diabetes Care, 28, 1916-1921.
https://doi.org/10.2337/diacare.28.8.1916
|
[26]
|
Kastelein, J.J., van der Stieg, W. and Holme, I. (2008) Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events with Statin Treatment. Circulation, 117, 3002-3009.
https://doi.org/10.1161/CIRCULATIONAHA.107.713438
|
[27]
|
Ballantyne, C.M., Raichlen, J.S. and Cain, V.A. (2008) Statin Therapy Alters the Relationship between Apolipoprotein B and Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Targets in High-Risk Patients: The MERCURY II (Measuring Effective Re-ductions in Cholesterol Using Rosuvastatin) Trial. Journal of the American College of Cardiology, 52, 626-632. https://doi.org/10.1016/j.jacc.2008.04.052
|
[28]
|
Robinson, J.G. (2009) Are You Targeting Non-High-Density Lip-oprotein Cholesterol? Journal of the American College of Cardiology, 55, 42-44. https://doi.org/10.1016/j.jacc.2009.07.056
|
[29]
|
Iyengar, S.S., Puri, R., Narasingan, S.N., Wangnoo, S.K., Mohan, V., Mohan, J.C., et al. (2016) Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: Part 1. Journal of the Association of Physicians of India, 64, 7-52.
|
[30]
|
Sarwar, N., Danesh, J., Eiriks-dottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S.M., Khaw, K.T. and Gudnason, V. (2007) Triglyc-erides and the Risk of Coronary Heart Disease: 10,158 Incident Cases among 262,525 Participants in 29 Western Pro-spective Studies. Circulation, 115, 450-458.
https://doi.org/10.1161/CIRCULATIONAHA.106.637793
|
[31]
|
Di Angelantonio, E., Sarwar, N., Perry, P., Kap-toge, S., Ray, K.K., Thompson, A., et al. (2009) Major Lipids, Apolipoproteins, and Risk of Vascular Disease. JAMA, 302, 1993-2000. https://doi.org/10.1001/jama.2009.1619
|
[32]
|
Stensvold, I., Tverdal, A., Urdal, P. and Graff-Iversen, S. (1993) Non-Fasting Serum Triglyceride Concentration and Mortality from Coronary Heart Disease and Any Cause in Middle Aged Norwegian Women. British Medical Journal, 307, 1318-1322. https://doi.org/10.1136/bmj.307.6915.1318
|
[33]
|
Stavenow, L. and Kjellström, T. (1999) Influence of Serum Tri-glyceride Levels on the Risk for Myocardial Infarction in 12,510 Middle Aged Males: Interaction with Serum Cholesterol. Atherosclerosis, 147, 243-247.
https://doi.org/10.1016/S0021-9150(99)00190-2
|
[34]
|
Jeppesen, J., Hein, H.O., Suadicani, P. and Gyntelberg, F. (1998) Triglyceride Concentration and Ischemic Heart Disease: An Eight-Year Follow-Up in the Copenhagen Male Study. Circulation, 97, 1029-1036.
https://doi.org/10.1161/01.CIR.97.11.1029
|
[35]
|
Hokanson, J.E. and Austin, M.A. (1996) Plasma Triglyceride Level Is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Me-ta-Analysis of Population-Based Prospective Studies. Journal of Cardiovascular Risk, 3, 213-219.
|
[36]
|
Nordestgaard, B.G., Benn, M., Schnohr, P. and Tybjaerg-Hansen, A. (2007) Nonfasting Triglycerides and Risk of Myocardial Infarc-tion, Ischemic Heart Disease, and Death in Men and Women. JAMA, 298, 299-308.
https://doi.org/10.1001/jama.298.3.299
|
[37]
|
Freiberg, J.J., Tybjaerg-Hansen, A., Jensen, J.S. and Nordestgaard, B.G. (2008) Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population. JAMA, 300, 2142-2152. https://doi.org/10.1001/jama.2008.621
|
[38]
|
Varbo, A. and Nordestgaard, B.G. (2018) Nonfasting Triglycerides, Low-Density Lipoprotein Cholesterol, and Heart Failure Risk: Two Cohort Studies of 113,554 Individuals. Arterioscle-rosis, Thrombosis, and Vascular Biology, 38, 464-472. https://doi.org/10.1161/ATVBAHA.117.310269
|
[39]
|
Nordestgaard, B.G. (2016) Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights from Epidemiology, Genetics, and Biology. Circulation Re-search, 118, 547-563.
https://doi.org/10.1161/CIRCRESAHA.115.306249
|
[40]
|
Klempfner, R., Erez, A., Sagit, B.Z., Goldenberg, I., Fisman, E., Kopel, E., et al. (2016) Elevated Triglyceride Level Is Independently Associated with Increased All-Cause Mortality in Patients with Established Coronary Heart Disease. Circulation: Cardiovascular Quality and Outcomes, 9, 100-108.
https://doi.org/10.1161/CIRCOUTCOMES.115.002104
|
[41]
|
Miller, M., Cannon, C.P., Murphy, S.A., Qin, J., Ray, K.K. and Braunwald, E. (2008) Impact of Triglyceride Levels beyond Low-Density Lipoprotein Cholesterol after Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial. Journal of the American College of Cardiology, 51, 724-730. https://doi.org/10.1016/j.jacc.2007.10.038
|
[42]
|
Mach, F., Baigent, C., Catapano, A.L., et al. (2020) 2019 ESC/EAS Guidelines for the Management of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk. European Heart Journal, 41, 111-118.
https://doi.org/10.1093/eurheartj/ehz455
|